Lastly, transcriptome profiling of IM-resistant GIST T-1R cells with inhibited or knocked-down CLDN1 (Figure 10B) illustrated the other potential targets that may be involved in GIST resistance to targeted therapies. Here, CLDN1 is linked to gastrointestinal stromal tumor.